| Characteristic | Branded generic | Originator | Unbranded generic |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
June 2020
More information
Region
Philippines
Survey time period
2007 to 2016
Supplementary notes
According to the source, the Philippine domestic pharmaceutical market is segmented into three license types of drugs:
(1) originators; (2) branded generics; and (3) unbranded generics. IQVIA defines originators as those drugs that are first to launch within a single or combined molecule. Meanwhile, branded generics, have the same molecule as the originator. Unbranded generics are those that carry the name of the molecule followed by its manufacturer.
Citation formats
